Accordingly, a global multicenter study of PD-L1 expression in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) reported that only 22% of the patients expressed PD-L1 levels greater than 50% (2). Here, CD274 is linked to non-small cell lung carcinoma.